According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...

Moderna (Nasdaq: MRNA) today reported financial results and provided business updates for the first quarter of 2025, which ...

US biotech major Biogen (Nasdaq: BIIB) reported stronger-than-expected earnings for the first quarter of 2025, helped by ...

UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump ...

Enara Bio, a privately-held UK biopharma developing bispecific T-cell engagers, has announced the appointment of Stacey Davis ...

US biotech Akari Therapeutics (Nasdaq: AKTX), which is developing novel payload antibody drug conjugates (ADCs), today ...

In one of the largest licensing deals in the Australian biotech industry, Dimerix Limited (ASX: DXB) has sealed an exclusive ...

Shares in US drug major Eli Lilly were a hefty 8% down early Thursday after the Indianapolis firm announced its first quarter financial results and latest guidance for 2025.

UK investment firm Aviva Capital Partners is supporting a major new life sciences expansion in south London, which aims to ...